Tag: Dolcas Biotech

A research study has confirmed the long-term safety of Dolcas Biotech’s CURCUGEN curcumin formulation. With multiple scientific evaluations already having established the oleoresin-based turmeric (Curcuma longa-L.) formulation’s bioefficacy and bioavailability, this recent preclinical safety evaluation demonstrated that there is no indication of any general toxicity, genotoxicity or adverse events...

A new study has demonstrated that Curcugen from Dolcas Biotech displays positive application in osteoarthritis and reduced analgesic use. Curcugen is a clean, dispersible, highly concentrated, clinically studied curcumin ingredient, fully derived from a turmeric base with a high curcuminoid concentration (50%). In a recently published peer-reviewed article, “An Investigation...